Short interest in Atossa Therapeutics Inc (NASDAQ:ATOS) increased during the last reporting period, rising from 7.14M to 7.62M. This put 5.9% of the company's publicly available shares short. Short ...
The latest price target for Atossa Therapeutics (NASDAQ:ATOS) was reported by Ascendiant Capital on December 8, 2025. The analyst firm set a price target for $8.00 expecting ATOS to rise to within 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results